News Focus
News Focus
Post# of 257253
Next 10
Followers 49
Posts 5519
Boards Moderated 0
Alias Born 07/19/2006

Re: genisi post# 82088

Monday, 08/10/2009 9:31:38 AM

Monday, August 10, 2009 9:31:38 AM

Post# of 257253
thanks genisi

"This SGP's presentation is news:

"High Sustained Virologic Response (SVR) in Genotype 1 (G1) Null Responders to Peg-Interfeon alfa-2b (P) plus Ribavirin (R) When Treated with Boceprevir (Boc) Combination Therapy.""

it sure is! It will be interesting to compare SVR to telaprevir - particularly since this is a much more homogeneous population to compare across studies

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now